RFCA
ABMD

R&F Capital Advisors’s Abiomed Inc ABMD Stock Holding History

R&F Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$522K Buy
+4,171
New +$483K 0.13% 237

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

R&F Capital Advisors's ABMD Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Abiomed Inc (ABMD) in Q1 2017: 4,171 shares worth $522K. The stake represents 0.13% of the portfolio and ranks #237 among its holdings.

287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

  • R&F Capital Advisors held 4,171 shares of Abiomed Inc worth $522K as of Q1 2017.
  • Abiomed Inc was a new R&F Capital Advisors position in Q1 2017.
  • Abiomed Inc made up 0.13% of R&F Capital Advisors's portfolio in Q1 2017, its #237 holding.
  • 287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.